Investing

JPMorgan has identified Viking Therapeutics as a key player in the GLP-1 boom, suggesting that the biopharmaceutical company has significant potential for growth. With an overweight rating and a price target of $80 per share, JPMorgan’s forecast indicates a substantial upside of more than 46% from the current market price. Viking Therapeutics is currently focused
0 Comments
As the broader equity markets experienced a sell-off following the latest inflation data, one particular industry stood out by surging higher – solar stocks. This surge was fueled by optimism surrounding renewable energy, particularly in anticipation of a potential victory by Vice President Kamala Harris in the upcoming November elections. Despite a challenging year in
0 Comments
The month of September started off on a rocky note for the stock market, especially in the semiconductor space. Nvidia experienced a significant drop in its market capitalization, marking it as the biggest one-day loss for any U.S. stock in history. The VanEck Semiconductor ETF (SMH) also suffered a nearly 12% decline last week, the
0 Comments
When looking for potential stock picks, it is imperative to consider the recommendations of top Wall Street analysts. One such recommendation is Planet Fitness (PLNT), a company that has recently displayed better-than-expected results for the second quarter. Baird analyst Jonathan Komp reaffirmed a buy rating on PLNT stock, stating that the company’s asset-light franchise model
0 Comments
Chip stocks have recently experienced a significant decline, with the VanEck Semiconductor ETF (SMH) sinking 11.7% in a four-day trading week, marking its worst week since March 2020. The sharp decline in chip stocks, particularly in artificial intelligence favorite Nvidia, has raised concerns over U.S. economic growth and added to the market’s volatility this summer.
0 Comments